Compagnie Lombard Odier SCmA’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
Sell
-260
Closed -$45K 1003
2015
Q1
$45K Buy
+260
New +$38.2K ﹤0.01% 796

Other funds holding SLXP

Compagnie Lombard Odier SCmA's SLXP Position: Q2 2015 in Review

Compagnie Lombard Odier SCmA sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 260 shares — an estimated $45K sold.

Compagnie Lombard Odier SCmA first reported a position in SLXP in Q1 2015 and held it in 1 quarter. The position peaked at $45K in Q1 2015. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

  • Compagnie Lombard Odier SCmA reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
  • Compagnie Lombard Odier SCmA sold 260 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $45K.
  • Compagnie Lombard Odier SCmA first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q1 2015 and held it in 1 quarter.
  • Compagnie Lombard Odier SCmA's SALIX PHARMACEUTICALS LTD DEL position peaked at $45K in Q1 2015.
  • 1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on Compagnie Lombard Odier SCmA's 13F filing for Q2 2015, filed 14 Aug 2015.